All Data requirements articles

  • RegOpsSPIN-Podcast-artwork-Webvision
    Podcasts

    RegRapPodIn Conversation with TOPRA’s RegOps SPIN

    BONUS EPISODE: In Conversation with TOPRA’s RegOps SPIN

  • AdobeStock_296252792
    Journal

    Regulatory complexities and challenges of biosimilars

    2022-06-15T10:09:00Z

    This continuing professional development (CPD) supplement focuses on the regulatory complexities and challenges associated with biosimilar products and their development. Although biosimilar products have been registered and approved for use in the EU for more than a decade, there is increasing speculation and excitement on the potential for biosimilars with increasingly complex structures, eg, multi-subunit, extensively post-translationally modified, and lipid-containing products.